| 标题 |
[求助补充材料] Phase 1 Dose‑Escalation Study of Mirvetuximab Soravtansine (IMGN853), a Folate Receptor α‑Targeting Antibody‑Drug Conjugate, in Patients With Solid Tumors
|
| 网址 |
求助人暂未提供
|
| DOI |
暂未提供,该求助的时间将会延长,查看原因?
|
| 其它 | DOI:10.1002/cncr.30736,Received:November 3, 2016;Revised:February 2, 2017;Accepted:March 20, 2017,Published onlineApril 25, 2017 in Wiley Online Library (wileyonlinelibrary.com) |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)